B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

T3 Clk

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with T3 Clk, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

lorecivivint
6 shared targets
demethylbellidifolin
6 shared targets
sotuletinib
4 shared targets
leucettamine
5 shared targets
pexidartinib
4 shared targets
barasertib
5 shared targets
semaxanib
4 shared targets
sel
4 shared targets
tandutinib
8 shared targets
elliptinium
2 shared targets
Loading evidence profile...

This evidence profile for T3 Clk is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.